Target intelligence / Profile preview

Bartter syndrome, infantile, with sensorineural deafness pseudogene

Molecular classification
Other (Pseudogene; not an active molecular entity like a channel, receptor, transporter, or enzyme)
01

Overview

This entry is a pseudogene related to Bartter syndrome, infantile, with sensorineural deafness (BSND pseudogene). Bartter syndrome is a group of rare renal tubular disorders involving defective salt reabsorption—mutations in the protein-coding BSND gene cause Bartter syndrome type IV, often associated with sensorineural deafness and impaired chloride channel function in the kidney. However, ENSG00000265233 refers to a nonfunctional pseudogene variant, which does not encode a protein or possess biological activity, and is not considered a direct target for drug development[1][5][3]. In summary, ENSG00000265233 is not a valid drug target; it is a pseudogene, not an active molecular entity. For drug targeting or disease mechanism, refer to the protein "Barttin" encoded by the functional BSND gene[1][5][3].

Other names
Bartter syndrome with sensorineural deafness pseudogeneBSND pseudogene

Beyond the preview

Go deeper on Bartter syndrome, infantile, with sensorineural deafness pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bartter syndrome, infantile, with sensorineural deafness pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call